| |
Latest 10 SEC filings (by transaction date) for RMD within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 6/24 | Mar 4/24 | Rider Michael J | Direct Ownership | ResMed Common Stock | S - Open market or private sale | -81 | $180.00 |
Mar 4/24 | Mar 1/24 | Rider Michael J | Direct Ownership | ResMed Common Stock | S - Open market or private sale | -200 | $173.25 |
Feb 23/24 | Feb 22/24 | Farrell Peter C | Direct Ownership | ResMed Common Stock | S - Open market or private sale | -10,935 | $182.66 |
Nov 29/23 | Nov 27/23 | Sandercock Brett | Direct Ownership | ResMed Common Stock | S - Open market or private sale | -3,000 | $152.62 |
Nov 27/23 | Nov 22/23 | Rider Michael J | Direct Ownership | ResMed Common Stock | G - Gift | -72 | |
Nov 20/23 | Nov 20/23 | Farrell Michael J. | Direct Ownership | ResMed Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -2,353 | $148.94 |
Nov 20/23 | Nov 20/23 | Douglas Robert Andrew | Direct Ownership | ResMed Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -1,375 | $148.94 |
Nov 20/23 | Nov 20/23 | Ghoshal Kaushik | Direct Ownership | ResMed Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -367 | $148.94 |
Nov 20/23 | Nov 20/23 | Farrell Michael J. | Direct Ownership | ResMed Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -2,353 | $148.94 |
Nov 21/23 | Nov 16/23 | Burt Carol | Direct Ownership | ResMed Common Stock | A - Grant, award or other under Rule 16b-3(d) | 1,768 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for RMD within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 6/24 | Mar 4/24 | Rider Michael J | Direct Ownership | ResMed Common Stock | S - Open market or private sale | -81 | $180.00 |
Mar 4/24 | Mar 1/24 | Rider Michael J | Direct Ownership | ResMed Common Stock | S - Open market or private sale | -200 | $173.25 |
Feb 23/24 | Feb 22/24 | Farrell Peter C | Direct Ownership | ResMed Common Stock | S - Open market or private sale | -10,935 | $182.66 |
Feb 23/24 | May 3/23 | Farrell Peter C | Direct Ownership | ResMed Common Stock | S - Open market or private sale | -12,600 | $237.17 |
Nov 29/23 | Nov 27/23 | Sandercock Brett | Direct Ownership | ResMed Common Stock | S - Open market or private sale | -3,000 | $152.62 |
Nov 27/23 | Nov 22/23 | Rider Michael J | Direct Ownership | ResMed Common Stock | G - Gift | -72 | |
Nov 21/23 | Nov 16/23 | Burt Carol | Direct Ownership | ResMed Common Stock | A - Grant, award or other under Rule 16b-3(d) | 1,768 | |
Nov 20/23 | Nov 16/23 | Farrell Michael J. | Direct Ownership | ResMed Common Stock Options | A - Grant, award or other under Rule 16b-3(d) | 55,468 | $148.90 |
Nov 20/23 | Nov 16/23 | Farrell Michael J. | Direct Ownership | ResMed Common Stock Options | M - Exercise or conversion exempt under rule 16b-3 | -3,462 | |
Nov 20/23 | Nov 20/23 | Farrell Michael J. | Direct Ownership | ResMed Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -2,353 | $148.94 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Intuitive Surgical (OQ:ISRG) |
Thermo Fisher Scientific (N:TMO) |
Edwards Lifesciences (N:EW) |